Advertisement
CNC vs MOH
Which Stock Would AI Choose? Centene Corporation (CNC) vs. Molina Healthcare (MOH) Stock Comparison
Key Takeaways
- CNC is executing a faster margin recovery, with management raising full-year adjusted EPS guidance after a strong earnings beat, while MOH is earlier in its turnaround and still absorbing Medicaid margin pressure.
- Centene's shares have delivered substantially stronger relative performance over the past year, while Molina's rebound has been more modest and remains tied to a Medicaid rate cycle that is only beginning to turn.
- Tickeron AI Verdict: Based on trend consistency, relative momentum, and margin-improvement catalysts, Tickeron's AI currently favors CNC over MOH.
- Both companies are heavily exposed to government-sponsored health programs, so Medicaid reimbursement rates, membership shifts, and regulatory policy are shared risk factors for each stock.
- For more detail, explore CNC Major News and CNC Today's Price Move, as well as MOH Major News and MOH Today's Price Move.
- To see how AI-powered systems are trading these and other tickers, visit Trending AI Robots.
Introduction
CNC (Centene Corporation) and MOH (Molina Healthcare) are two of the largest managed care organizations in the United States, each focused primarily on government-sponsored health plans such as Medicaid, Medicare, and Affordable Care Act (ACA) Marketplace coverage. Because both names operate in the same sector and face overlapping regulatory and reimbursement pressures, a stock comparison between them offers investors a useful lens on how two similar businesses can diverge in momentum and execution. This comparison is especially relevant for traders and investors monitoring the managed care recovery, where margin trends, membership shifts, and state rate cycles are shaping market sentiment and relative performance.
CNC Overview and Recent Performance
Centene Corporation is one of the nation's largest managed care providers, serving members across Medicaid, Medicare, and Marketplace segments. In recent weeks, Centene has reinforced its position as a turnaround story. The company's latest quarterly results exceeded expectations, with revenue growth and adjusted earnings per share (EPS) well above consensus, driven by strength in its Medicare and Marketplace businesses and disciplined cost management in Medicaid. Management raised its full-year adjusted EPS guidance and signaled that Medicare Advantage reached financial breakeven ahead of schedule.
This progress follows a challenging period in which Centene withdrew guidance amid higher medical costs, so the recent recovery reflects improved pricing, better medical cost trends, and tighter operational controls. Over the past year, the stock has delivered a significant rally, and it now trades near the upper end of its 52-week range. Sentiment has shifted from concern over medical cost trends toward optimism about margin recovery, though membership attrition in Medicaid remains a key watch item.
MOH Overview and Recent Performance
Molina Healthcare provides managed care services primarily to low-income individuals and families through Medicaid, Medicare, and Marketplace programs. Its recent market activity reflects a company still working through elevated medical costs. Recent quarterly results beat consensus on both revenue and adjusted EPS, and management reaffirmed full-year guidance, pointing to early signs that Medicaid margins are stabilizing after a multi-year downturn.
Unlike Centene, Molina's revenue and membership have been declining on a year-over-year basis as it reduces its Marketplace footprint and exits underperforming Medicare Advantage (MAPD) products. The company is positioning itself around its Medicaid dual-eligible (duals) business and newly won state contracts, including a large Florida contract, which management expects to contribute meaningfully to earnings in 2027 and beyond. Molina's shares have rebounded in recent weeks, but the stock's forward valuation remains elevated relative to its current earnings, reflecting the market's anticipation of a recovery that has not yet fully materialized.
Trending AI Robots
Tickeron operates hundreds of AI-powered trading bots that collectively trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance record, and set of covered securities. Because not every bot is suited to every market environment, Tickeron curates only the strongest and most appropriate strategies into its Trending AI Robots section, where traders can review the bots currently positioned for prevailing conditions. These systems vary widely in approach, from short-term momentum strategies to longer-horizon trend-following models, giving investors a range of ways to compare how AI evaluates tickers such as CNC and MOH. Exploring the Trending AI Robots page can help traders assess which automated strategies align with their own objectives.
Head-to-Head Comparison
While Centene and Molina compete in similar government-sponsored markets, their current positioning differs in important ways. Centene is a larger, more diversified operator with a market capitalization roughly three times Molina's, and it is further along in its margin recovery. Its Medicare Advantage business has reached breakeven ahead of plan, and its Marketplace segment is generating improving margins. Centene also trades at a relatively modest forward price-to-earnings multiple, supported by analysts' consensus "Buy" rating.
Molina, by contrast, is more concentrated in Medicaid and is deliberately shrinking its Marketplace and general Medicare Advantage exposure to focus on higher-return dual-eligible products and newly won contracts. Its growth narrative rests heavily on a 2027 Medicaid rate cycle and the ramp-up of recent contract wins, which introduces more execution and timing risk in the near term. Both stocks share sector-level risks, including federal and state reimbursement decisions, membership attrition from eligibility reviews and work requirements, and medical cost inflation, but Centene's demonstrated momentum and earlier-stage margin expansion give it a clearer near-term trajectory.
Tickeron AI Verdict
Based on observable factors such as trend consistency, relative momentum, margin-improvement catalysts, and valuation positioning, Tickeron's AI would likely favor CNC over MOH in the current environment. Centene's stronger recent price performance, earlier achievement of breakeven in Medicare Advantage, and upward guidance revisions indicate more established trend strength, whereas Molina's recovery remains more dependent on future rate cycles and contract execution. This probabilistic assessment reflects the balance of current data rather than a definitive prediction of future returns.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNC is a StrongBuy and MOH is a StrongBuy.
CNC's RSI Oscillator soars into overbought territory
The RSI Oscillator for CNC moved into overbought territory on November 04, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 60 cases where CNC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
CNC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on CNC as a result. In 65 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for CNC just turned positive on November 04, 2026. Looking at past instances where CNC's MACD turned positive, the stock continued to rise in 29 of 49 cases over the following month. The odds of a continued upward trend are 59%.
CNC moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CNC crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 48%.
Following a +14.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNC advanced for three days, in 186 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Aroon Indicator entered an Uptrend today. In 143 of 213 cases where CNC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 10 (best 1 - 100 worst), indicating outstanding price growth. CNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.664) is normal, around the industry mean (3.512). P/E Ratio (-7.358) is within average values for comparable stocks, (126.100). Projected Growth (PEG Ratio) (0.754) is also within normal values, averaging (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.160) is also within normal values, averaging (0.569).
The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Momentum Indicator for MOH turns positive, indicating new upward trend
MOH saw its Momentum Indicator move above the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In 64 of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 52 cases where MOH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for MOH just turned positive on November 04, 2026. Looking at past instances where MOH's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.
MOH moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MOH crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +4.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOH advanced for three days, in 210 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 151 of 222 cases where MOH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MOH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
MOH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 22 (best 1 - 100 worst), indicating outstanding price growth. MOH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.834) is normal, around the industry mean (3.512). MOH's P/E Ratio (1415.125) is considerably higher than the industry average of (126.100). Projected Growth (PEG Ratio) (0.880) is also within normal values, averaging (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.233) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MOH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
CNC | MOH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 89 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 46 Fair valued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 87 | 100 | |
SMR RATING 1..100 | 95 | 90 | |
PRICE GROWTH RATING 1..100 | 10 | 22 | |
P/E GROWTH RATING 1..100 | 51 | 1 | |
SEASONALITY SCORE 1..100 | 1 | 39 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CNC's Valuation (46) in the Managed Health Care industry is somewhat better than the same rating for MOH (99). This means that CNC’s stock grew somewhat faster than MOH’s over the last 12 months.
CNC's Profit vs Risk Rating (87) in the Managed Health Care industry is in the same range as MOH (100). This means that CNC’s stock grew similarly to MOH’s over the last 12 months.
MOH's SMR Rating (90) in the Managed Health Care industry is in the same range as CNC (95). This means that MOH’s stock grew similarly to CNC’s over the last 12 months.
CNC's Price Growth Rating (10) in the Managed Health Care industry is in the same range as MOH (22). This means that CNC’s stock grew similarly to MOH’s over the last 12 months.
MOH's P/E Growth Rating (1) in the Managed Health Care industry is somewhat better than the same rating for CNC (51). This means that MOH’s stock grew somewhat faster than CNC’s over the last 12 months.
| CNC | MOH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 80% | 1 day ago 67% |
| Stochastic ODDS (%) | 1 day ago 70% | 1 day ago 71% |
| Momentum ODDS (%) | 1 day ago 71% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 59% | 1 day ago 70% |
| TrendWeek ODDS (%) | 1 day ago 63% | 1 day ago 73% |
| TrendMonth ODDS (%) | 1 day ago 63% | 1 day ago 72% |
| Advances ODDS (%) | 1 day ago 61% | 3 days ago 67% |
| Declines ODDS (%) | 3 days ago 64% | 8 days ago 65% |
| BollingerBands ODDS (%) | 1 day ago 75% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 67% | 1 day ago 68% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNC’s FA Score shows that 1 FA rating(s) are green while MOH’s FA Score has 2 green FA rating(s).
- CNC’s FA Score: 1 green, 4 red.
- MOH’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNC’s TA Score shows that 6 TA indicator(s) are bullish while MOH’s TA Score has 7 bullish TA indicator(s).
- CNC’s TA Score: 6 bullish, 4 bearish.
- MOH’s TA Score: 7 bullish, 3 bearish.
Price Growth
CNC (@Managed Health Care) experienced а +13.36% price change this week, while MOH (@Managed Health Care) price change was +14.30% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +4.35%. For the same industry, the average monthly price growth was +7.51%, and the average quarterly price growth was +19.94%.
Reported Earning Dates
CNC is expected to report earnings on Feb 09, 2027.
MOH is expected to report earnings on Feb 10, 2027.
Industries' Descriptions
@Managed Health Care (+4.35% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
Advertisement